000 01762 a2200481 4500
005 20250514073648.0
264 0 _c20030821
008 200308s 0 0 eng d
022 _a0022-3042
024 7 _a10.1046/j.1471-4159.2003.01844.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHope, Andrew D
245 0 0 _aAlzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression.
_h[electronic resource]
260 _bJournal of neurochemistry
_cJul 2003
300 _a394-404 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlzheimer Disease
_xmetabolism
650 0 4 _aCanavanine
_xpharmacology
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xmetabolism
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aGreen Fluorescent Proteins
650 0 4 _aHeat-Shock Proteins
_xbiosynthesis
650 0 4 _aHumans
650 0 4 _aLuminescent Proteins
_xgenetics
650 0 4 _aMolecular Chaperones
_xbiosynthesis
650 0 4 _aNeuroblastoma
_xmetabolism
650 0 4 _aOxidative Stress
_xgenetics
650 0 4 _aPeptide Hydrolases
_xdrug effects
650 0 4 _aProteasome Endopeptidase Complex
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aTransfection
650 0 4 _aTransgenes
650 0 4 _aTumor Cells, Cultured
650 0 4 _aUbiquitin
_xgenetics
700 1 _ade Silva, Rohan
700 1 _aFischer, David F
700 1 _aHol, Elly M
700 1 _avan Leeuwen, Fred W
700 1 _aLees, Andrew J
773 0 _tJournal of neurochemistry
_gvol. 86
_gno. 2
_gp. 394-404
856 4 0 _uhttps://doi.org/10.1046/j.1471-4159.2003.01844.x
_zAvailable from publisher's website
999 _c12649119
_d12649119